IXHL
Incannex Healthcare Inc.
Price Chart
Latest Quote
$3.20
-0.05 (-1.54%)
Current Price
| Previous Close | $3.25 |
| Open | $3.35 |
| Day High | $3.50 |
| Day Low | $3.12 |
| Volume | 514,425 |
Stock Information
| Shares Outstanding | 11.96M |
| Total Debt | $114K |
| Cash Equivalents | $74.45M |
| Net Income | $-48.41M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $38.29M |
| EPS (TTM) | $-16.62 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-36.05M |
| Income | $-48.41M |
| Book/sh | $5.50 |
| Cash/sh | $6.22 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 41.47 |
| Current Ratio | 41.56 |
| Debt/Eq | 0.15 |
Returns & Margins
| ROA | -32.19% |
| ROE | -117.17% |
Ownership
| Insider Ownership | 12.34% |
| Institutional Ownership | 12.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.93 |
| P/B | 0.58 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $17.57 |
Technical Indicators
| SMA20 | $3.43 |
| SMA50 | $3.77 |
| SMA200 | $8.31 |
| RSI | 52.58 |
| ATR | 0.4063 |
| Shares Float | 9.87M |
| Short Float | 7.06% |
| Short Ratio | 3.01 |
| Volatility | 2.84 |
| Rel Volume | 1.64 |
Performance History
| Week | -13.51% |
| Month | -4.76% |
| Quarter | -0.62% |
| 6 Months | -75.92% |
| YTD | -72.65% |
| Year | -51.52% |
| 3 Years | -98.56% |
| 10 Years | -99.82% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $3.20 | 514,425 |
| 2026-06-24 | $3.25 | 151,200 |
| 2026-06-23 | $3.31 | 98,100 |
| 2026-06-22 | $3.25 | 382,000 |
| 2026-06-18 | $3.56 | 266,200 |
| 2026-06-17 | $3.70 | 310,500 |
| 2026-06-16 | $3.73 | 198,300 |
| 2026-06-15 | $3.67 | 294,500 |
| 2026-06-12 | $3.83 | 359,500 |
| 2026-06-11 | $3.82 | 374,400 |
| 2026-06-10 | $3.91 | 581,100 |
| 2026-06-09 | $3.67 | 453,400 |
| 2026-06-08 | $3.40 | 861,100 |
| 2026-06-05 | $2.92 | 289,900 |
| 2026-06-04 | $3.09 | 134,800 |
| 2026-06-03 | $3.06 | 175,500 |
| 2026-06-02 | $3.05 | 231,900 |
| 2026-06-01 | $3.25 | 211,300 |
| 2026-05-29 | $3.35 | 170,400 |
| 2026-05-28 | $3.55 | 227,500 |
| 2026-05-27 | $3.25 | 254,800 |
| 2026-05-26 | $3.36 | 292,500 |
About Incannex Healthcare Inc.
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
đ° Latest News
Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26
Insider Monkey âĸ 2026-03-03T20:24:00Z
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive âĸ 2026-01-26T14:55:16ZWhat Makes Incannex Healthcare Inc. (IXHL) a New Buy Stock
Zacks âĸ 2025-12-01T17:00:04Z
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires âĸ 2025-08-22T19:43:48ZWall Street Set to Open Higher Friday as Investors Await Powell's Speech at Jackson Hole
MT Newswires âĸ 2025-08-22T12:57:46ZIncannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea
Insider Monkey âĸ 2025-08-17T05:56:26Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | - | $12,000 | $0 | $0 |
| Operating Revenue | - | $12,000 | $0 | $0 |
| Reconciled Cost Of Revenue | - | - | $0 | $4,360 |
| Cost Of Revenue | - | - | $0 | $4,360 |
| Expenses | ||||
| Other Non Operating Income Expenses | $-796,000 | - | $1,376,645 | $788,654 |
| Total Expenses | - | $18,619,000 | $13,638,000 | $10,164,241 |
| Rent Expense Supplemental | - | $348,000 | $84,000 | $77,280 |
| Other Income Expense | - | $-28,000 | $-35,414,000 | $-92,610 |
| Net Non Operating Interest Income Expense | - | $206,000 | $241,000 | $4,314 |
| Operating Expense | - | $18,619,000 | $13,638,000 | $10,159,881 |
| Other Operating Expenses | - | $-11,434,000 | $-683,000 | - |
| Selling And Marketing Expense | - | $1,055,000 | $1,249,000 | $1,889,154 |
| General And Administrative Expense | - | $16,016,000 | $6,675,000 | $5,113,610 |
| Income & Earnings | ||||
| Normalized Income | $-23,199,000 | $-18,439,400 | $-13,397,000 | $-10,159,927 |
| Net Income From Continuing Operation Net Minority Interest | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Net Interest Income | - | $206,000 | $241,000 | $4,314 |
| Interest Income | - | $206,000 | $241,000 | $4,314 |
| Net Income From Continuing And Discontinued Operation | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Total Operating Income As Reported | - | $-30,041,000 | $-49,668,000 | - |
| Net Income Common Stockholders | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Net Income | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Net Income Including Noncontrolling Interests | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Net Income Continuous Operations | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Pretax Income | - | $-18,429,000 | $-48,811,000 | $-10,252,538 |
| Special Income Charges | - | $0 | $-35,347,000 | $-92,610 |
| Interest Income Non Operating | - | $206,000 | $241,000 | $4,314 |
| Operating Income | - | $-18,607,000 | $-13,638,000 | $-10,164,241 |
| Depreciation Amortization Depletion Income Statement | - | $103,000 | $88,000 | $0 |
| Depreciation And Amortization In Income Statement | - | $103,000 | $88,000 | $0 |
| Depreciation Income Statement | - | $103,000 | $88,000 | $0 |
| Gross Profit | - | - | $0 | $-4,360 |
| Per Share | ||||
| Diluted EPS | $-40.50 | $-34.50 | $-1.03 | $-1.03 |
| Basic EPS | $-40.50 | $-34.50 | $-1.03 | $-1.03 |
| Other | ||||
| Normalized EBITDA (Bullshit earnings) | $-22,650,000 | $-18,298,000 | $21,864,000 | $-10,071,631 |
| Total Unusual Items | $-23,686,000 | $-28,000 | $-35,414,000 | $-92,610 |
| Total Unusual Items Excluding Goodwill | $-23,686,000 | $-28,000 | $-35,414,000 | $-92,610 |
| Diluted Average Shares | $1,148,475 | $538,811 | $12,806,883 | $9,926,283 |
| Basic Average Shares | $1,148,475 | $538,811 | $12,806,883 | $9,926,283 |
| Gain On Sale Of Security | $-22,214,000 | $-28,000 | $-67,000 | - |
| Tax Effect Of Unusual Items | - | $-8,400 | $0 | $0 |
| Tax Rate For Calcs | - | $0 | $0 | $0 |
| Reconciled Depreciation | - | $103,000 | $88,000 | $0 |
| EBITDA (Bullshit earnings) | - | $-18,326,000 | $-13,550,000 | $-10,164,241 |
| EBIT | - | $-18,429,000 | $-13,638,000 | $-10,164,241 |
| Diluted NI Availto Com Stockholders | - | $-18,459,000 | $-48,811,000 | $-10,252,538 |
| Tax Provision | - | $30,000 | $0 | $0 |
| Research And Development | - | $12,879,000 | $6,309,000 | $3,695,326 |
| Selling General And Administration | - | $17,071,000 | $7,924,000 | $7,002,764 |
| Other Gand A | - | $3,931,000 | $2,090,000 | $2,641,902 |
| Rent And Landing Fees | - | $348,000 | $84,000 | $77,280 |
| Salaries And Wages | - | $11,737,000 | $4,501,000 | $2,394,427 |
| Other Special Charges | - | - | $35,347,000 | - |
| Write Off | - | - | $0 | $92,610 |
| Other Taxes | - | - | $-671,119 | $-538,209 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Total Assets | - | $17,047,000 | $23,783,000 | $26,057,735 |
| Total Non Current Assets | - | $845,000 | $786,000 | $0 |
| Current Assets | - | $16,202,000 | $22,997,000 | $26,057,735 |
| Prepaid Assets | - | $329,000 | $686,000 | $41,162 |
| Receivables | - | $10,015,000 | $191,000 | $219,334 |
| Taxes Receivable | - | $10,015,000 | $191,000 | $202,739 |
| Cash Cash Equivalents And Short Term Investments | - | $5,858,000 | $22,120,000 | $25,797,239 |
| Cash And Cash Equivalents | - | $5,858,000 | $22,120,000 | $25,797,239 |
| Goodwill And Other Intangible Assets | - | - | $34,895,333 | $0 |
| Other Current Assets | - | - | $1,035,181 | - |
| Notes Receivable | - | - | $66,199 | $16,595 |
| Accounts Receivable | - | - | $287,478 | - |
| Cash Financial | - | - | $22,084,177 | $25,797,239 |
| Other Receivables | - | - | - | - |
| Gross Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | - | $373,000 | $521,000 | $0 |
| Long Term Debt And Capital Lease Obligation | - | $210,000 | $408,000 | $0 |
| Current Debt And Capital Lease Obligation | - | $163,000 | $113,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | - | $5,830,000 | $2,958,000 | $1,383,064 |
| Total Non Current Liabilities Net Minority Interest | - | $210,000 | $408,000 | $0 |
| Current Liabilities | - | $5,620,000 | $2,550,000 | $1,383,064 |
| Current Deferred Liabilities | - | $85,000 | $0 | - |
| Payables And Accrued Expenses | - | $5,039,000 | $2,174,000 | $1,180,552 |
| Payables | - | $527,000 | $1,748,000 | $894,761 |
| Accounts Payable | - | $527,000 | $1,748,000 | $894,761 |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Total Equity Gross Minority Interest | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Stockholders Equity | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Gains Losses Not Affecting Retained Earnings | - | $-3,332,000 | $-3,255,000 | - |
| Retained Earnings | - | $-110,671,000 | $-92,212,000 | $-40,445,566 |
| Other Equity Interest | - | - | $7,983,615 | $5,556,375 |
| Other Equity Adjustments | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $6,479,333 | $588,094 | $529,003 | $430,778 |
| Share Issued | $6,479,333 | $588,094 | $529,003 | $430,778 |
| Tangible Book Value | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Invested Capital | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Working Capital | - | $10,582,000 | $20,447,000 | $24,674,670 |
| Capital Lease Obligations | - | $373,000 | $521,000 | $0 |
| Total Capitalization | - | $11,217,000 | $20,825,000 | $24,674,670 |
| Foreign Currency Translation Adjustments | - | $-3,332,000 | $-3,255,000 | - |
| Additional Paid In Capital | - | $125,218,000 | $116,290,000 | - |
| Capital Stock | - | $2,000 | $2,000 | $59,563,861 |
| Common Stock | - | $2,000 | $2,000 | $59,563,861 |
| Preferred Stock | - | $0 | $0 | - |
| Long Term Capital Lease Obligation | - | $210,000 | $408,000 | $0 |
| Current Deferred Revenue | - | $85,000 | $0 | - |
| Current Capital Lease Obligation | - | $163,000 | $113,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | - | $333,000 | $263,000 | $202,512 |
| Current Accrued Expenses | - | $4,512,000 | $426,000 | $285,791 |
| Net PPE | - | $845,000 | $786,000 | $0 |
| Accumulated Depreciation | - | $-126,000 | $-23,000 | - |
| Gross PPE | - | $971,000 | $809,000 | $0 |
| Construction In Progress | - | $0 | $160,000 | - |
| Machinery Furniture Equipment | - | $598,000 | $157,000 | - |
| Buildings And Improvements | - | $373,000 | $492,000 | - |
| Properties | - | $0 | $0 | - |
| Treasury Shares Number | - | - | $0 | $0 |
| Other Properties | - | - | $1,187,386 | - |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-16,122,000 | $-11,065,000 | $-8,810,311 | $-5,191,576 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,845,000 | $-10,749,000 | $-8,810,311 | $-5,191,576 |
| Cash Flow From Continuing Operating Activities | $-15,845,000 | $-10,749,000 | $-8,810,311 | $-5,191,576 |
| Operating Gains Losses | $28,000 | - | - | - |
| Cash Flowsfromusedin Operating Activities Direct | - | $-15,942,825 | $-12,807,373 | $-5,191,952 |
| Other Cash Paymentsfrom Operating Activities | - | $-17,285,861 | - | - |
| Classesof Cash Receiptsfrom Operating Activities | - | $1,013,879 | $782,383 | $1,507,427 |
| Other Cash Receiptsfrom Operating Activities | - | $1,013,879 | $782,383 | $82,807 |
| Investing Activities | ||||
| Capital Expenditure | $-277,000 | $-316,000 | - | - |
| Investing Cash Flow | $-277,000 | $-316,000 | $0 | $21,997 |
| Cash Flow From Continuing Investing Activities | $-277,000 | $-316,000 | $0 | $21,997 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $8,175,000 | $28,331,329 | $9,317,132 |
| Financing Cash Flow | $0 | $8,175,000 | $28,331,329 | $9,317,132 |
| Cash Flow From Continuing Financing Activities | $0 | $8,175,000 | $28,331,329 | $9,317,132 |
| Net Common Stock Issuance | $0 | $8,175,000 | $28,331,329 | $9,317,132 |
| Common Stock Issuance | $0 | $8,175,000 | $28,331,329 | $9,317,132 |
| Other | ||||
| End Cash Position | $5,858,000 | $22,120,000 | $25,797,239 | $6,854,914 |
| Beginning Cash Position | $22,120,000 | $25,834,000 | $6,276,221 | $2,707,362 |
| Effect Of Exchange Rate Changes | $-140,000 | $-824,000 | $0 | $0 |
| Changes In Cash | $-16,122,000 | $-2,890,000 | $19,521,018 | $4,147,553 |
| Net PPE Purchase And Sale | $-277,000 | $-316,000 | $0 | $0 |
| Purchase Of PPE | $-277,000 | $-316,000 | $0 | - |
| Change In Working Capital | $-6,445,000 | $35,825,000 | $843,638 | $4,329 |
| Change In Other Current Assets | $0 | $35,347,000 | $36,767 | $129 |
| Change In Payables And Accrued Expense | $3,023,000 | $1,104,000 | $764,322 | $-218,873 |
| Change In Payable | $3,023,000 | $1,104,000 | - | - |
| Change In Prepaid Assets | $369,000 | $-626,000 | - | - |
| Change In Receivables | $-9,837,000 | $0 | $-63,508 | $161,465 |
| Stock Based Compensation | $8,928,000 | $2,149,000 | $1,007,478 | $450,835 |
| Depreciation Amortization Depletion | $103,000 | $88,000 | $0 | $0 |
| Depreciation And Amortization | $103,000 | $88,000 | $0 | $0 |
| Net Foreign Currency Exchange Gain Loss | $28,000 | $0 | - | - |
| Net Income From Continuing Operations | $-18,459,000 | $-48,811,000 | $-10,252,538 | $-8,544,809 |
| Repayment Of Debt | - | $-36,219 | $0 | - |
| Net Issuance Payments Of Debt | - | $-36,219 | $0 | - |
| Net Long Term Debt Issuance | - | $-36,219 | $0 | - |
| Long Term Debt Payments | - | $-36,219 | $0 | - |
| Change In Other Current Liabilities | - | $68,335 | $106,057 | $-76,006 |
| Other Non Cash Items | - | $-4,255 | $-408,889 | $2,909,703 |
| Interest Received Direct | - | $329,157 | $6,271 | $73,065 |
| Classesof Cash Payments | - | $-17,285,861 | $-13,596,027 | $-6,772,444 |
| Receiptsfrom Customers | - | $0 | $0 | $1,507,427 |
| Net Business Purchase And Sale | - | - | $0 | $21,997 |
| Sale Of Business | - | - | $0 | $21,997 |
| Sale Of PPE | - | - | $0 | $0 |
| Change In Inventory | - | - | $0 | $137,614 |
| Provisionand Write Offof Assets | - | - | $0 | $-11,634 |
| Paymentson Behalfof Employees | - | - | $-13,596,027 | $-8,969,276 |
| Paymentsto Suppliersfor Goodsand Services | - | - | - | $-6,772,444 |
Fetched: 2026-06-21